Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
50%
Ph phase_2
2
33%
Ph phase_3
1
17%

Phase Distribution

3

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
3(50.0%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(3)

Detailed Status

Completed3
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (50.0%)
Phase 22 (33.3%)
Phase 31 (16.7%)

Trials by Status

completed350%
recruiting350%

Recent Activity

3 active trials
Showing 5 of 6
completedphase_1

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

NCT06929156
recruitingphase_2

A Study of BGM0504 in Participants With Obesity

NCT06911203
recruitingphase_3

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

NCT07064486
recruitingphase_1

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

NCT07166081
completedphase_1

A Study of BGM0504 in Overweight or Obese Participants

NCT06920056
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06929156Phase 1

A Study of BGM0504 in Healthy Participants and Participants With Impaired Renal Function

Completed
NCT06911203Phase 2

A Study of BGM0504 in Participants With Obesity

Recruiting
NCT07064486Phase 3

A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

Recruiting
NCT07166081Phase 1

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM0504 Tablets in Non-diabetic Overweight or Obese Adult Subjects

Recruiting
NCT06920056Phase 1

A Study of BGM0504 in Overweight or Obese Participants

Completed
NCT06973681Phase 2

A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6